LEE011
CLEE011A2115C
Phase 1 small_molecule completed
Quick answer
LEE011 for Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer is a Phase 1 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed